Related references
Note: Only part of the references are listed.ALTERATIONS OF ADIPONECTIN IN THE COURSE OF INFLAMMATION AND SEVERE SEPSIS
Michael Behnes et al.
SHOCK (2012)
Leptin Exacerbates Sepsis-Mediated Morbidity and Mortality
Nathan I. Shapiro et al.
JOURNAL OF IMMUNOLOGY (2010)
Sepsis induced changes of adipokines and cytokines - septic patients compared to morbidly obese patients
Andreas Hillenbrand et al.
BMC SURGERY (2010)
The diagnostic value of serum leptin monitoring and its correlation with tumor necrosis factor-alpha in critically ill patients: a prospective observational study
Ayman Abd Al-Maksoud Yousef et al.
CRITICAL CARE (2010)
Adiponectin, retinol-binding protein 4, and leptin in protracted critical illness of pulmonary origin
Lies Langouche et al.
CRITICAL CARE (2009)
Levels of oxidized low-density lipoproteins are increased in patients with severe sepsis
Michaet Behnes et al.
JOURNAL OF CRITICAL CARE (2008)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
Time-course of neopterin levels in patients suffering from severe sepsis treated with and without Drotrecogin-alpha (activated)
Michael Behnes et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2008)
The emerging role of adipokines as mediators of inflammation and immune responses
Francisca Lago et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2007)
Towards a pro-inflammatory and immunomodulatory emerging role of leptin
M. Otero et al.
RHEUMATOLOGY (2006)
Recombinant human activated protein C
Martin Hughes
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Mechanisms of action of recombinant human activated protein C
M. Brueckmann et al.
ANAESTHESIST (2006)
Adipose tissue, adipokines, and inflammation
G Fantuzzi
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2005)
Dynamic evolution of coagulopathy in the first day of severe sepsis: Relationship with mortality and organ failure
JF Dhainaut et al.
CRITICAL CARE MEDICINE (2005)
Adipokines: inflammation and the pleiotropic role of white adipose tissue
P Trayhurn et al.
BRITISH JOURNAL OF NUTRITION (2004)
Drotrecogin alfa (activated) inhibits NF-kappa B activation and MIP-1-alpha release from isolated mononuclear cells of patients with severe sepsis
M Brueckmann et al.
INFLAMMATION RESEARCH (2004)
Activated protein C inhibits the release of macrophage inflammatory protein-1-alpha from THP-1 cells and from human monocytes
M Brueckmann et al.
CYTOKINE (2004)
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
MM Levy et al.
CRITICAL CARE MEDICINE (2003)
Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective
T Cheng et al.
NATURE MEDICINE (2003)
Recombinant human activated protein C attenuates the inflammatory response in endothelium and monocytes by modulating nuclear factor-κB
DE Joyce et al.
CRITICAL CARE MEDICINE (2002)
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
Jo Vandesompele et al.
GENOME BIOLOGY (2002)
Humoral markers of severity and prognosis of critical illness
ES Nylén et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
DC Angus et al.
CRITICAL CARE MEDICINE (2001)
Chemokines control fat accumulation and leptin secretion by cultured human adipocytes
CC Gerhardt et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2001)
Efficacy and safety of recombinant human activated protein C for severe sepsis.
GR Bernard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Regulation by cytokines of leptin expression in human bone marrow adipocytes
P Laharrague et al.
HORMONE AND METABOLIC RESEARCH (2000)
Tumor necrosis factor-α inhibits leptin production in subcutaneous and omental adipocytes from morbidly obese humans
RL Fawcett et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Share Paper
